BIOMAT Database Logo BIOMAT Database Logo

[Protease inhibitors of the human immunodeficiency virus]. 1998

B Roca, and E Simón

UI MeSH Term Description Entries
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV

Related Publications

B Roca, and E Simón
Human immunodeficiency virus protease inhibitors.
January 1999, Pharmacotherapy,
B Roca, and E Simón
Human immunodeficiency virus protease inhibitors.
December 2003, The Pediatric infectious disease journal,
B Roca, and E Simón
Inhibitors of human immunodeficiency virus-1 protease.
May 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire,
B Roca, and E Simón
Human immunodeficiency virus type 1 protease inhibitors.
May 1997, Archives of internal medicine,
B Roca, and E Simón
Intracellular accumulation of human immunodeficiency virus protease inhibitors.
October 2002, Antimicrobial agents and chemotherapy,
B Roca, and E Simón
Human immunodeficiency virus protease inhibitors and Pneumocystis carinii.
June 2002, The Journal of infectious diseases,
B Roca, and E Simón
Protease inhibitors for the treatment of human immunodeficiency virus infection.
February 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
B Roca, and E Simón
Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors.
June 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
B Roca, and E Simón
Novel macromolecular inhibitors of human immunodeficiency virus-1 protease.
July 2008, Protein engineering, design & selection : PEDS,
B Roca, and E Simón
Naturally occurring protease inhibitors potent against the human immunodeficiency virus.
October 1996, Biochemical and biophysical research communications,
Copied contents to your clipboard!